As a potent driver of cell malignancy, PRMT5 is involved in multiple cell survival and proliferation pathways including DDR, p53 activation, cell cycle regulation, and c-Myc in tumor cells through protein arginine methylation and downstream effects such as RNA splicing regulation. This evidence concerns the gene TP53 and neoplasm.